AU2002313236A1 - Medicinal compositions - Google Patents
Medicinal compositionsInfo
- Publication number
- AU2002313236A1 AU2002313236A1 AU2002313236A AU2002313236A AU2002313236A1 AU 2002313236 A1 AU2002313236 A1 AU 2002313236A1 AU 2002313236 A AU2002313236 A AU 2002313236A AU 2002313236 A AU2002313236 A AU 2002313236A AU 2002313236 A1 AU2002313236 A1 AU 2002313236A1
- Authority
- AU
- Australia
- Prior art keywords
- medicinal compositions
- medicinal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-180373 | 2001-06-14 | ||
JP2001180373 | 2001-06-14 | ||
JP2001298839 | 2001-09-28 | ||
JP2001-298839 | 2001-09-28 | ||
PCT/JP2002/005954 WO2002102414A1 (en) | 2001-06-14 | 2002-06-14 | Medicinal compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2002313236B8 AU2002313236B8 (en) | 2003-01-02 |
AU2002313236A1 true AU2002313236A1 (en) | 2003-05-15 |
AU2002313236B2 AU2002313236B2 (en) | 2007-07-26 |
Family
ID=26616910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002313236A Ceased AU2002313236B2 (en) | 2001-06-14 | 2002-06-14 | Medicinal compositions |
Country Status (9)
Country | Link |
---|---|
US (3) | US6884768B2 (en) |
EP (2) | EP1407785A4 (en) |
KR (3) | KR20090019915A (en) |
CN (2) | CN100350977C (en) |
AU (1) | AU2002313236B2 (en) |
CA (2) | CA2662967C (en) |
MX (1) | MXPA03011538A (en) |
TW (1) | TWI239247B (en) |
WO (1) | WO2002102414A1 (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE44578E1 (en) | 2000-04-10 | 2013-11-05 | Teva Pharmaceutical Industries, Ltd. | Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids |
US20050032811A1 (en) | 2003-08-06 | 2005-02-10 | Josiah Brown | Methods for administering aripiprazole |
WO2005023225A1 (en) * | 2003-09-05 | 2005-03-17 | Ranbaxy Laboratories Limited | Cilostazol adsorbate |
JP4836797B2 (en) | 2003-10-23 | 2011-12-14 | 大塚製薬株式会社 | Controlled release sterile injection aripiprazole formulations and methods |
HUE038247T2 (en) | 2004-05-19 | 2018-10-29 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Injectable coposition comprising sodium deoxycholate |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
US20060127468A1 (en) * | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US20140162965A1 (en) | 2004-08-25 | 2014-06-12 | Aegis Therapeutics, Inc. | Compositions for oral drug administration |
US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
US9114069B2 (en) * | 2004-08-25 | 2015-08-25 | Aegis Therapeutics, Llc | Antibacterial compositions for drug administration |
US20110257096A1 (en) * | 2004-08-25 | 2011-10-20 | Aegis Therapeutics, Inc. | Compositions for drug administration |
US20090047347A1 (en) * | 2005-07-29 | 2009-02-19 | Aegis Therapeutics, Inc. | Compositions for Drug Administration |
US20060046962A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
WO2006030301A1 (en) * | 2004-09-17 | 2006-03-23 | Ranbaxy Laboratories Limited | Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers |
TWI363626B (en) * | 2004-11-15 | 2012-05-11 | Otsuka Pharma Co Ltd | Aqueous ophthalmic suspension of crystalline rebamipide |
CA2622758A1 (en) | 2005-09-15 | 2007-03-29 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
US8920918B2 (en) * | 2005-10-31 | 2014-12-30 | Kee Action Sports Technology Holdings, Llc | Oil and polyethylene glycol fill material for use in paintball shells |
TW200808375A (en) * | 2006-05-12 | 2008-02-16 | Otsuka Pharma Co Ltd | Hydrogel suspension and manufacturing process thereof |
US8226949B2 (en) | 2006-06-23 | 2012-07-24 | Aegis Therapeutics Llc | Stabilizing alkylglycoside compositions and methods thereof |
US20080075785A1 (en) * | 2006-09-22 | 2008-03-27 | San-Laung Chow | Controlled release hydrogel formulation |
US20110165236A1 (en) * | 2006-09-22 | 2011-07-07 | Biokey, Inc. | Controlled release hydrogel formulation |
TWI415629B (en) * | 2006-10-26 | 2013-11-21 | Otsuka Pharma Co Ltd | Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
EP2167068A2 (en) * | 2007-07-05 | 2010-03-31 | Inserm-Institut National De La Sante Et De La Recherche Medicale | Anticonvulsive pharmaceutical compositions |
EP2011491A1 (en) * | 2007-07-05 | 2009-01-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anticonvulsive pharmaceutical compositions |
AR067747A1 (en) | 2007-07-31 | 2009-10-21 | Otsuka Pharma Co Ltd | METHODS TO PRODUCE SUSPENSION OF ARIPIPRAZOL AND LIOFILIZED FORMULATION |
EP2180882B2 (en) * | 2007-10-19 | 2017-06-28 | Otsuka Pharmaceutical Co., Ltd. | Solid matrix pharmaceutical preparation |
ES2586032T3 (en) | 2008-03-28 | 2016-10-11 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
EP2165702B1 (en) | 2008-09-17 | 2011-11-16 | Helm AG | Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation |
US8440631B2 (en) | 2008-12-22 | 2013-05-14 | Aegis Therapeutics, Llc | Compositions for drug administration |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
EP2418945B1 (en) * | 2009-04-15 | 2018-12-05 | BMG PHARMA S.p.A. | Mineral salt-sulfonic acid compositions and methods of use |
CN102145003B (en) * | 2010-02-08 | 2015-04-22 | 张立英 | Medicinal composition containing insoluble medicament |
EP2608781A4 (en) * | 2010-08-04 | 2014-01-29 | Tixupharma | Inclusion complexes of cyclodextrins with spermidine, and proliferative/reparative compositions comprising thereof |
PL2898881T3 (en) * | 2010-08-04 | 2019-04-30 | Pierrel Pharma S R L | Compositions comprising supramolecular complexes of polyanionic polymers and spermidine for use in the treatment of periodontum and damaged oral tissue |
KR101277021B1 (en) * | 2010-12-28 | 2013-06-24 | 주식회사 드림파마 | Oral controlled release double-layered rebamipide-contained formulation using gastro-retentive drug delivery system and process for the preparation thereof |
MX363465B (en) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Treatment of submental fat. |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
ES2917973T3 (en) | 2011-06-14 | 2022-07-12 | Neurelis Inc | Benzodiazepine administration |
CN102357084B (en) * | 2011-10-11 | 2014-02-26 | 广东彼迪药业有限公司 | Enalapril maleate tablet composition and its preparation and use |
US10918612B2 (en) * | 2013-01-22 | 2021-02-16 | Markus Zwickl | Combinations with 2-aminoethanesulfonic acid |
US20160136282A1 (en) * | 2014-11-18 | 2016-05-19 | Genovate Biotechnology Co., Ltd. | Novel formulation of cilostazol, a quinolinone-derivative used for alleviating the symptom of intermittent claudication in patients with peripheral vascular disease |
PE20180690A1 (en) | 2015-04-27 | 2018-04-23 | Intercept Pharmaceuticals Inc | OBETICOLIC ACID COMPOSITIONS AND METHODS OF USE |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4591605A (en) | 1981-11-10 | 1986-05-27 | Research Foundation Of State University Of New York | Method and ingestible formulation for inhibiting the secretion of stomach acid |
NZ212053A (en) * | 1984-05-17 | 1988-02-29 | Merrell Dow Pharma | Polyamine containing pharmaceutical compositions for treating neoplasms |
JP2911496B2 (en) * | 1989-09-11 | 1999-06-23 | 帝國製薬株式会社 | Highly absorbable vaginal agent containing bioactive polypeptide |
JPH03275633A (en) * | 1990-03-23 | 1991-12-06 | Teikoku Seiyaku Co Ltd | Absorbefacient for physiologically active polypeptide |
US5328844A (en) * | 1990-05-09 | 1994-07-12 | University Of Colorado Foundation, Inc. | Culture media for mammalian cells |
JPH0733667A (en) * | 1992-07-03 | 1995-02-03 | Japan Tobacco Inc | Aqueous solution of 4,6-o-hydroxyphosphorylglucosamine derivative and method of making the same derivative water-soluble |
JPH0656643A (en) * | 1992-08-03 | 1994-03-01 | Shiseido Co Ltd | Skin preparation for external use |
JPH06192108A (en) * | 1992-12-25 | 1994-07-12 | Kanebo Ltd | Calcium gluconate oral solution |
JP3690820B2 (en) | 1993-02-25 | 2005-08-31 | 雪印乳業株式会社 | Nutritional composition for infants |
SE9404196D0 (en) | 1994-12-02 | 1994-12-02 | Astra Ab | New antithrombotic formulation |
JP3297969B2 (en) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | Eye drops |
AU4357096A (en) | 1995-01-10 | 1996-07-31 | Otsuka Pharmaceutical Co., Ltd. | Resin particle, medical material and pharmaceutical preparation containing said resin particle |
WO1996023490A1 (en) * | 1995-02-03 | 1996-08-08 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
JPH1025255A (en) * | 1996-07-11 | 1998-01-27 | Taisho Pharmaceut Co Ltd | Scarcely soluble agent improved in solubility |
JP3677376B2 (en) * | 1996-08-13 | 2005-07-27 | 武田薬品工業株式会社 | Medicine |
JPH10262607A (en) | 1997-03-28 | 1998-10-06 | Snow Brand Milk Prod Co Ltd | Nutrient composition for infant |
JPH1160487A (en) * | 1997-06-09 | 1999-03-02 | Taisho Pharmaceut Co Ltd | Vitamin b1 derivative-formulated solution |
JPH1160486A (en) * | 1997-06-09 | 1999-03-02 | Taisho Pharmaceut Co Ltd | Thiamin-mixed liquid formulation |
JP4403590B2 (en) * | 1997-10-02 | 2010-01-27 | 大正製薬株式会社 | Vitamin B1 combination liquid |
JP4390030B2 (en) * | 1997-12-03 | 2009-12-24 | 大正製薬株式会社 | Minoxidil combination liquid composition |
EP1113785B1 (en) * | 1998-07-24 | 2005-04-13 | Seo Hong Yoo | Clear aqueous solutions of bile acids |
US6207190B1 (en) * | 1998-08-13 | 2001-03-27 | Chronorx, Llc | Dosage forms for the treatment of the chronic glaucomas |
-
2002
- 2002-06-14 EP EP02738715A patent/EP1407785A4/en not_active Withdrawn
- 2002-06-14 AU AU2002313236A patent/AU2002313236B2/en not_active Ceased
- 2002-06-14 CN CNB028118693A patent/CN100350977C/en not_active Expired - Fee Related
- 2002-06-14 KR KR1020097000807A patent/KR20090019915A/en not_active Application Discontinuation
- 2002-06-14 CN CN2005101272199A patent/CN1813699B/en not_active Expired - Fee Related
- 2002-06-14 CA CA2662967A patent/CA2662967C/en not_active Expired - Fee Related
- 2002-06-14 CA CA2449952A patent/CA2449952C/en not_active Expired - Fee Related
- 2002-06-14 MX MXPA03011538A patent/MXPA03011538A/en active IP Right Grant
- 2002-06-14 TW TW091113019A patent/TWI239247B/en not_active IP Right Cessation
- 2002-06-14 KR KR1020087001568A patent/KR100994221B1/en not_active IP Right Cessation
- 2002-06-14 EP EP13153254.1A patent/EP2591806A1/en not_active Withdrawn
- 2002-06-14 KR KR1020037016321A patent/KR100943309B1/en not_active IP Right Cessation
- 2002-06-14 WO PCT/JP2002/005954 patent/WO2002102414A1/en active Application Filing
- 2002-06-14 US US10/480,598 patent/US6884768B2/en not_active Expired - Fee Related
-
2004
- 2004-12-15 US US11/011,035 patent/US7008920B2/en not_active Expired - Fee Related
- 2004-12-15 US US11/011,278 patent/US7531499B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002313236A1 (en) | Medicinal compositions | |
AU781269C (en) | Pharmaceutical compositions | |
EP1407785A4 (en) | Medicinal compositions | |
HK1065944A1 (en) | Medicinal compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AU2002258221A1 (en) | Medicinal composition | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2002365093A1 (en) | Therapeutic compositions | |
AUPR600601A0 (en) | Therapeutic compositions | |
AU2002321808A1 (en) | Dental compositions | |
AU2002354460A1 (en) | Medicinal composition | |
AUPR529701A0 (en) | Pharmaceutical composition | |
AU2001282541A1 (en) | Medicinal compositions | |
AU2002346223A1 (en) | Medicinal compositions | |
AU2001285737A1 (en) | Pharmaceutical compositions | |
EP1413314A4 (en) | Medicinal compositions | |
AU2002256916A1 (en) | Medicinal compositions | |
AU2002327341A1 (en) | Thrombomodulin-containing medicinal compositions | |
AU2002306341A1 (en) | Medicinal compositions | |
AU2002226759A1 (en) | Medicinal composition | |
AU2002326822A1 (en) | Pro-micelle pharmaceutical compositions | |
AU2002100921A4 (en) | Pharmaceutical composition |